November 28, 2014
Mr Ito (left), Rei Naito, Senior Manager of Healthcare Policy, Public Affairs, Legal & Compliance Allergan Japan is setting its sights on the Japanese eyelash care market, armed with the company’s hoped-to-be flagship eyelash hypotrichosis drug, GlashVista (bimatoprost). “We’re aiming...read more